Mendez S - Search Results

1

Immunological and pathological evaluation of rhesus macaques infected with Leishmania major.

Freidag BL, Mendez S, Cheever AW, Kenney RT, Flynn B, Sacks DL, Seder RA. Freidag BL, et al. Among authors: mendez s. Exp Parasitol. 2003 Mar-Apr;103(3-4):160-8. doi: 10.1016/s0014-4894(03)00099-7. Exp Parasitol. 2003. PMID: 12880593

2

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection.

Rhee EG, Mendez S, Shah JA, Wu CY, Kirman JR, Turon TN, Davey DF, Davis H, Klinman DM, Coler RN, Sacks DL, Seder RA. Rhee EG, et al. Among authors: mendez s. J Exp Med. 2002 Jun 17;195(12):1565-73. doi: 10.1084/jem.20020147. J Exp Med. 2002. PMID: 12070284 Free PMC article.

3

Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.

Anderson CF, Mendez S, Sacks DL. Anderson CF, et al. Among authors: mendez s. J Immunol. 2005 Mar 1;174(5):2934-41. doi: 10.4049/jimmunol.174.5.2934. J Immunol. 2005. PMID: 15728505

4

Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease.

Lira R, Méndez S, Carrera L, Jaffe C, Neva F, Sacks D. Lira R, et al. Among authors: mendez s. Exp Parasitol. 1998 Jul;89(3):331-42. doi: 10.1006/expr.1998.4283. Exp Parasitol. 1998. PMID: 9676711

5

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, Wynn TA, Sacks DL. Belkaid Y, et al. Among authors: mendez s. J Exp Med. 2001 Nov 19;194(10):1497-506. doi: 10.1084/jem.194.10.1497. J Exp Med. 2001. PMID: 11714756 Free PMC article.

6

CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, Bertholet S, Udey MC, Sacks D. Belkaid Y, et al. Among authors: mendez s. J Immunol. 2002 Apr 15;168(8):3992-4000. doi: 10.4049/jimmunol.168.8.3992. J Immunol. 2002. PMID: 11937556

7

Optimization of DNA vaccination against cutaneous leishmaniasis.

Méndez S, Belkaid Y, Seder RA, Sacks D. Méndez S, et al. Vaccine. 2002 Nov 1;20(31-32):3702-8. doi: 10.1016/s0264-410x(02)00376-6. Vaccine. 2002. PMID: 12399198

8

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. Belkaid Y, et al. Among authors: mendez s. Nature. 2002 Dec 5;420(6915):502-7. doi: 10.1038/nature01152. Nature. 2002. PMID: 12466842

9

Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice.

Shah JA, Darrah PA, Ambrozak DR, Turon TN, Mendez S, Kirman J, Wu CY, Glaichenhaus N, Seder RA. Shah JA, et al. Among authors: mendez s. J Exp Med. 2003 Jul 21;198(2):281-91. doi: 10.1084/jem.20030645. J Exp Med. 2003. PMID: 12874261 Free PMC article.

10

Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability.

Mendez S, Tabbara K, Belkaid Y, Bertholet S, Verthelyi D, Klinman D, Seder RA, Sacks DL. Mendez S, et al. Infect Immun. 2003 Sep;71(9):5121-9. doi: 10.1128/IAI.71.9.5121-5129.2003. Infect Immun. 2003. PMID: 12933855 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters